Unlocking the Potential of ctDNA in Colorectal Cancer Management

In this week’s podcast, we will provide updates the emerging roles of circulating tumor DNA (ctDNA) in managing colorectal cancer. We are joined by Michael Brian LaPelusa, MD, University of Texas MD Anderson Cancer Center, Houston, TX; Juan Manuel O’Connor, MD, MSc, Instituto Alexander Fleming, Buenos Aires, Argentina; Anup Kasi, MD, MPH, University of Kansas Cancer Center, Kansas City, KS; Giulia Martini, MD, PhD, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy; and Kanwal Pratap Singh Raghav, MBBS, MD, The University of Texas MD Anderson Cancer Center, Houston, TX. The role of ctDNA in predicting treatment responses and assessing minimal residual disease (MRD) will be discussed. Biomarker-driven treatment strategies assessed in the TACT-D, and CAPRI 2-GOIM trials will additionally be evaluated in this week’s podcast.